{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-002723","form_type":"8-K","ticker":null,"cik":"0000922247","company_name":"Cyclo Therapeutics, Inc.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.823318+00:00","generated_at":"2026-05-27T03:50:29.898957+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cyclo Therapeutics extends merger deadline to March 31, 2025 and issues $2M convertible note to Rafael","bullets":["Merger Agreement End Date extended from Feb 15 to March 31, 2025 via Amendment No. 2 with Rafael Holdings.","Company issued $2M convertible promissory note to Rafael (5% interest, matures March 31, 2025) for working capital.","Prior notes' maturity dates also extended to March 31, 2025.","Rafael Holdings owns ~39.5% of Cyclo common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-002723","json":"https://secwatch.observer/filing/0001437749-25-002723.json","markdown":"https://secwatch.observer/filing/0001437749-25-002723.md","text":"https://secwatch.observer/filing/0001437749-25-002723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/0001437749-25-002723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/ctdh20250204_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:50:29.898957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e3d4f79878d9041fce4bbad26f6a705d8c52d2a8","claim":"Cyclo Therapeutics, Inc. incurred convertible notes of $2,000,000.00 with Rafael at 5% per annum maturing March 31, 2025.","evidence_excerpt":"Eighth Amended and Restated Note Purchase Agreement (the “Agreement”) with Rafael pursuant to which the Company issued and sold a convertible promissory note in the principal amount of $2,000,000.00 (the “Note”) to Rafael.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/0001437749-25-002723-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$2,000,000.00"},{"label":"Counterparty","value":"Rafael"},{"label":"Rate","value":"5% per annum"},{"label":"Maturity","value":"March 31, 2025"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}